New Psychoactive Substances

This presentation was featured at Indonesia 2025, on the 18.09.2025. Authors: Supiyanto 1 and Tanti 2 1 Chief of The Center of Narcotics Laboratory, National Narcotics Board of The Republic of Indonesia 2 Research Team Leader, Center of...

Mental health disorders and substance use disorders (SUDs) in particular, contribute greatly to the global burden of disease. Psychedelics, including entactogens and dissociative substances, are currently being explored for the treatment of...

ISSUP Pakistan present their Webinar on New Psychoactive Substances – Designer Benzodiazepines.

We invite specialists of the Ministry of Health of the Republic of Kazakhstan, the Ministry of Internal Affairs of the Republic of Kazakhstan, the Kazakh Scientific Center of Dermatology and Infectious Diseases, representatives of UNODC, UNAIDS, non-governmental organizations, heads and doctors of regional Mental Health Centers.

According to the International Standards for the Treatment of Drug Use Disorders (2020), the use of psychoactive drugs or narcotic drugs and psychotropic substances without medical supervision is associated with significant health risks...

Various NPS have significantly changed the picture of drug use in different countries. They are now very prominent in the drug market. Indeed, many of these substances are intended to circumvent drug laws and are sold as ‘legal’...

ISSUP Kazakhstan presented the Third Webinar in the Series on New Psychoactive Substances, with a focus on Black market and policy of new psychoactive substances in the Asia region.